Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amino acid and peptide transporters represent a broad class of membrane transport proteins, predominantly within the Solute Carrier (SLC) superfamily, responsible for the translocation of amino acids, dipeptides, and tripeptides across biological membranes (Source: UniProt). These transporters, including the SLC15 (peptide) and SLC1, SLC6, and SLC7 (amino acid) families, play vital roles in nutrient absorption in the gut, renal reabsorption, and the regulation of neurotransmitter levels in the central nervous system (Source: PubMed, PMID: 29070610). In oncology, specific transporters like the Large Neutral Amino Acids Transporter 1 (LAT1/SLC7A5) are frequently overexpressed to support the increased protein synthesis and metabolic requirements of tumor cells, serving as both diagnostic biomarkers and therapeutic targets (Source: NIH, National Cancer Institute). Furthermore, these transporters are strategically utilized in pharmacology to improve the pharmacokinetics of drugs; for example, the prodrug valacyclovir is designed to be a substrate for the PEPT1 transporter to enhance its oral bioavailability (Source: PubChem). Genetic mutations in these transporters lead to various metabolic disorders, such as Hartnup disease and lysinuric protein intolerance, emphasizing their critical role in systemic homeostasis (Source: StatPearls).
The primary mechanisms of action include competitive inhibition of substrate transport to starve metabolic pathways (particularly in cancer) and the use of transporters as vehicles for prodrug delivery to increase systemic absorption and cellular entry.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amino acid and peptide transporter (SLC) (SLC).